Skip to main navigation Skip to search Skip to main content

In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid

  • Victor Masseno
  • , Steven Muriithi
  • , Alexis Nzila*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

We tested the effect of probenecid and verapamil in chemosensitizing Plasmodium falciparum to 14 antimalarials using the multidrug-resistant strain V1S and the drug-sensitive 3D7. Verapamil chemosensitizes V1S to quinine and chloroquine. Interestingly, probenecid profoundly chemosensitizes V1S to piperaquine. Thus, probenecid could be used to increase piperaquine efficacy in vivo.

Original languageEnglish
Pages (from-to)3131-3134
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume53
Issue number7
DOIs
StatePublished - Jul 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid'. Together they form a unique fingerprint.

Cite this